Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1995;252(Suppl 1):S22–S26. doi: 10.1007/BF02484430

Mechanisms of nasal hyper-reactivity

M Andersson 1,✉, L Greiff 1, C Svensson 1, C Persson 2
PMCID: PMC7087639  PMID: 7734972

Abstract

Hyper-reactivity to non-specific challenges has been considered a hallmark of asthma and is defined as an abnormal responsiveness of the bronchial airways to a variety of provocative agents. The mechanisms underlying hyper-reactivity in the upper and lower airways are not known. By using the nose to study the inflammatory response possible abnormalities can be investigated carefully and pathophysiology of specific airway hyper-reactivities can be better understood. Other factors than merely constriction of the bronchial smooth muscles can cause narrowing of the free lumen to airflow. Functionally different and very distinct mucosal end-organ reactivities may also be increased. If these reactivities can be well assessed, specific airway hyper-reactivity can be defined. In the present report, specific mucosal end-organ hyper-reactivites in the allergic nasal mucosa are presented. Certain widespread hypotheses, such as the role of the eosinophil and the “increased absorption permeability theory”, are disputed.

Key words: Allergic rhinitis, Inflammation, Bronchial hyper-reactivity, Plasma exudation

References

  • 1.Andersson M, Pipkorn U. Allergen induced hyperreactivity is not a feature of dermal immedite allergic reactions - in contrast to reactions of airways mucosa. Clin Allergy. 1988;18:189–196. doi: 10.1111/j.1365-2222.1988.tb02858.x. [DOI] [PubMed] [Google Scholar]
  • 2.Andersson M, Pipkorn U. Immediate and late allergic skin reactions are not inducers of local specific and unspecific reactions. Allergy 1988. 1988;43:824–830. doi: 10.1111/j.1398-9995.1988.tb00933.x. [DOI] [PubMed] [Google Scholar]
  • 3.Andersson M, von Kogerer B, Andersson P, Pipkorn U. Allergen-induced nasal hyperreactivity appears unrelated to the size of the nasal and dermal immediate allergic reaction. Allergy. 1987;42:631–637. doi: 10.1111/j.1398-9995.1987.tb00395.x. [DOI] [PubMed] [Google Scholar]
  • 4.Andersson M, Andersson P, Pipkorn U. Topical glucocorticosteroids and allergen-induced increase in nasal reactivity; relationship between treatment time and inhibitory effect. J Allergy Clin Immunol. 1989;82:1019–1026. doi: 10.1016/0091-6749(88)90139-X. [DOI] [PubMed] [Google Scholar]
  • 5.Bacon JR, McLean JA, Matthews KP, Banas JM. Priming of the nasal mucosa by ragweed extract or by an irritant (ammonia) J Allergy Clin Immunol. 1982;67:111–116. doi: 10.1016/0091-6749(81)90005-1. [DOI] [PubMed] [Google Scholar]
  • 6.Borum P. Nasal methacholine test. A measurement of nasal reactivity. J Allergy Clin Immunol. 1979;63:253–257. doi: 10.1016/0091-6749(79)90109-X. [DOI] [PubMed] [Google Scholar]
  • 7.Borum P, Grönborg H, Brofeldt S, Mygind N. Nasal reactivity in rhinintis. Eur J Resp Dis. 1983;64:65–71. [PubMed] [Google Scholar]
  • 8.Boushey HA, Holtzman MJ, Sheller JR, Nadel JA. Bronchial hyperreactivity. Am Rev Respir Dis. 1980;121:389–413. doi: 10.1164/arrd.1980.121.2.389. [DOI] [PubMed] [Google Scholar]
  • 9.Connell JT. Quantitative intranasal pollen challenges: the priming effect in allergic rhinitis. J Allergy. 1969;43:33–44. doi: 10.1016/0021-8707(69)90018-5. [DOI] [PubMed] [Google Scholar]
  • 10.Cuss FM, Dixon CMS, Barnes PJ. Effects of inhaled platelet activating factor on pulmonary function and bronchial responsiveness in man. Lancet. 1986;11:189–192. doi: 10.1016/S0140-6736(86)92489-X. [DOI] [PubMed] [Google Scholar]
  • 11.De Monchy JGR, Kaufmann HF, Venge P, Koeter GH, Jansen HM, Sluiter HJ, deVries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis. 1985;131:373–376. doi: 10.1164/arrd.1985.131.3.373. [DOI] [PubMed] [Google Scholar]
  • 12.Flavahan NA, Slifman NR, Gleich GJ, Vanhoutte PH. Human major basic protein causes hyperreactivity of respiratory smooth muscle: role of the epithelium. Am Rev Respir Dis. 1988;138:685–688. doi: 10.1164/ajrccm/138.3.685. [DOI] [PubMed] [Google Scholar]
  • 13.Friegas E, Loegering DA, Gleich GJ. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest. 1980;42:35–43. [PubMed] [Google Scholar]
  • 14.Gleich GJ, Flavahan NA, Fujisawa T, Vanhoutte PM. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J Allergy Clin Immunol. 1988;81:776–781. doi: 10.1016/0091-6749(88)90931-1. [DOI] [PubMed] [Google Scholar]
  • 15.Greiff L, Svensson C, Andersson M, Åkerlund A, Wollmer P, Alkner U, Persson CGA. Increased exudative responsiveness in allergen- and coronavirus-induced airway inflammation. Allergy. 1993;48:91–91. [Google Scholar]
  • 16.Greiff L, Wollmer P, Svensson C, Andersson M, Persson CGA. Effect of seasonal allergic rhinitis on airway mucosal absorption of chromium-51 labelled EDTA. Thorax. 1993;48:648–650. doi: 10.1136/thx.48.6.648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Greiff L, Wollmer P, Svensson C, Andersson M, Persson CGA. Effect of seasonal allergic rhinitis on airway mucosal absorption of chromium-51 labelled EDTA. Thorax. 1993;48:648–650. doi: 10.1136/thx.48.6.648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Grönborg H, Borum P, Mygind N. Histamine and methacholine do not increase nasal reactivity. Clin Allergy. 1986;16:597–602. doi: 10.1111/j.1365-2222.1986.tb01999.x. [DOI] [PubMed] [Google Scholar]
  • 19.Hargreave FE, Ryan G, Thomson NC, O'Byrne PM, Latimer K, Juniper EF, Dolovich J. Bronchial responsiveness to histamine and methacholine in asthma; measurement and clinical significance. J Allergy Clin Immunol. 1981;68:347–355. doi: 10.1016/0091-6749(81)90132-9. [DOI] [PubMed] [Google Scholar]
  • 20.Henocq E, Vargaftig BB (1986) Accumulation of eosinophils in response to intracutaneous PAF-acether and allergen in man. Lancet II: 1378–1379 [DOI] [PubMed]
  • 21.Kaliner M, Barnes PJ, Persson CGA. Asthma. Its pathology and treatment, vol 49. New York: Dekker; 1991. pp. 1–778. [Google Scholar]
  • 22.Klementsson M, Andersson M. The eosinophil chemotactic activity of topical PAF on the human nasal mucosa. Eur J Clin Pharmacol. 1992;42:295–299. doi: 10.1007/BF00266351. [DOI] [PubMed] [Google Scholar]
  • 23.Klementsson H, Andersson M, Baumgarten C, Venge P, Pipkorn U. Changes in non-specific nasal reactivity and eosinophil influx and activation after allergen challenge. Clin Exp Allergy. 1990;20:539–547. doi: 10.1111/j.1365-2222.1990.tb03147.x. [DOI] [PubMed] [Google Scholar]
  • 24.Klementsson H, Andersson M, Pipkorn U. Allergen-induced increase in non-specific nasal reactivity is blocked by antihistamines without a clearcut relationship to eosinophil influx. J Allergy Clin Immunol. 1990;86:466–472. doi: 10.1016/s0091-6749(05)80201-5. [DOI] [PubMed] [Google Scholar]
  • 25.Klementsson H, Andersson M, Venge P, Pipkorn U. Allergen-induced changes in nasal secretory responsiveness and eosinophil granulocytes. Acta Otolaryngol (Stockh) 1991;42:631–637. doi: 10.3109/00016489109138412. [DOI] [PubMed] [Google Scholar]
  • 26.Klementsson H, Svensson C, Andersson M, Venge P, Pipkorn U. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the allergic nasal mucosa during a weak pollen season. Clin Exp Allergy. 1991;21:705–710. doi: 10.1111/j.1365-2222.1991.tb03199.x. [DOI] [PubMed] [Google Scholar]
  • 27.Metzger WJ, Zaval D, Richerson HB, Moseley P, Iwamota P, Monick M, Sjoerdsma K, Hunninghake GW. Local allergen challenge and bronchioalveolar lavage of allergic asthmatic lungs. Am Rev Respir Dis. 1987;135:433–440. doi: 10.1164/arrd.1987.135.2.433. [DOI] [PubMed] [Google Scholar]
  • 28.Mygind N. Essential allergy. Oxford: Blackwell; 1986. [Google Scholar]
  • 29.Naclerio RM, Togias A, Proud D, Kagey-Sobotka A, Adkinson NF, Jr, Plant M, Norman PS, Lichtenstein LM. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985;313:65–70. doi: 10.1056/NEJM198507113130201. [DOI] [PubMed] [Google Scholar]
  • 30.Pipkorn U, Proud D, Schleimer RP, Peters SP, Adkinsson NF, Kagey-Sobotka A, Norman PS, Lichtenstein LM, Naclerio RM. Effects of short term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest. 1987;80:957–961. doi: 10.1172/JCI113188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Salomonsson P, Grbnneberg R, Gilljam H, Andersson O, Billing O, Enander I, Persson CGA. Bronchial exudation of bulk plasma at allergen challenge in allergic asthma. Am Rev Respir Dis. 1992;146:1535–1542. doi: 10.1164/ajrccm/146.6.1535. [DOI] [PubMed] [Google Scholar]
  • 32.Schmekel B. A critical view on lavage sampling techniques. In: Persson CGA, Brattsand R, Laitinen LA, Venge P, editors. Inflammatory indices in chronic bronchitis. Berlin: Birkhäuser; 1990. pp. 133–143. [Google Scholar]
  • 33.Svensson C (1990) Exudation of plasma into human airways. On the regulation of exudative responses in human nasal mucosa. Thesis. Lund, University Hospital, l-164
  • 34.Svensson C, Andersson M, Alkner U, Venge P, Persson CGA, Pipkorn U. Albumin bradyknins and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure. J Allergy Clin Immunol. 1990;85:828–833. doi: 10.1016/0091-6749(90)90064-B. [DOI] [PubMed] [Google Scholar]
  • 35.Svensson C, Andersson M, Grönnerberg R, Andersson O, Billing B, Gilljam H, Greiff L, Alkner U, Persson CGA. Allergen-challenge-induced exudation of alpha2-macroglobulin across nasal and bronchial mucosa (abstract) Allergy. 1993;48:9–9. doi: 10.1111/j.1398-9995.1993.tb04754.x. [DOI] [PubMed] [Google Scholar]

Articles from European Archives of Oto-Rhino-Laryngology are provided here courtesy of Nature Publishing Group

RESOURCES